Clinical trial

Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)

NCT00682383

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-09-01

PhasePHASE2

Study timeline

Study start (unknown)2003-09-01Date precision: month

Registry last updated2012-10-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Unresectable Locally Advanced NSCLCunresolved

Interventions

Cisplatin; Etoposide; Radiation therapy; Docetaxel; NeulastaDRUG

Sponsors & collaborators

Mt. Sinai Medical Center, Miamilead sponsor

Amgencollaborator

Mapped research locations

Miami BeachFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00682383 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.